Second Genome Appoints Dr. Susannah Cantrell to Chief Business Officer and Dr. Preeti Gupta Lal to Chief Scientific Officer
January 25, 2021, Brisbane, CA
Second Genome To Present Biomarker Data in Oncology at Keystone Symposium
January 19, 2021, South San Francisco, CA
Second Genome To Present at Biotech Showcase Digital 2021 Conference
January 11, 2021, South San Francisco, CA
Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery
April 6, 2020, Foster City, CA & South San Francisco, CA
FORTUNE and Great Place to Work Name Second Genome a "Top 10 Best Workplace in Biopharma"
April 10, 2019, South San Francisco, CA
Second Genome Expands Development of CNS Platform to Validate Microbial Products as Therapeutics for Autism Spectrum Disorder
March 26, 2019, South San Francisco
Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For The Treatment Of Nonalcoholic Steatohepatitis (NASH)
January 23, 2019, South San Francisco
Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer
September 26, 2018, South San Francisco, CA
